title: Should access to medicines and TRIPS flexibilities be limited to specific diseases?
authors.affiliation: Boston University School of Law, USA.
authors.forename: Kevin
authors.initials: K
authors.lastname: Outterson
mesh_terms: D017281:Cost of Illness; D004194:Disease / Q000145:classification*; D004358:Drug Therapy; D006297:Health Services Accessibility; D006801:Humans; D007391:International Cooperation; D010067:Ownership; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D004364:Pharmaceutical Preparations / Q000191:economics; D011634:Public Health
chemical_list: D004364:Pharmaceutical Preparations